(Q34204223)

31 July 2017

1 reference

title

Quality of reporting of meta-analyses: the QUOROM statement. Will it help? (English)

1 reference

31 July 2017

0 references

Christensen E

1

1 reference

31 July 2017

1 February 2001

1 reference

31 July 2017

Journal of Hepatology

1 reference

31 July 2017

34

1 reference

31 July 2017

342-345

1 reference

31 July 2017

2

1 reference

Meta-analyses of randomized controlled trials.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Interferon as treatment for acute hepatitis C. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Role of vasoactive drugs in the treatment of bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Quality assessment of reports on clinical trials in the Journal of Hepatology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Randomized clinical trials in HEPATOLOGY: predictors of quality.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Do certain countries produce only positive results? A systematic review of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Why review articles on the health effects of passive smoking reach different conclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900002-7

7 January 2021

10.1016/S0168-8278(00)00002-7

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11281568